Assignee
HAYDEN MICHAEL
CA·2 granted patents·15 pending applications·42 citations·filing 1992–2018
Top patents by PatentIndex Score
17 records- 0191US8679750B2Methods and compositions for the treatment of Huntington'S diseaseHAYDEN MICHAEL·Filed 2009·Granted Mar 25, 2014·26 cites·8 claims
- 0265US2019117639A1Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2018·Application pending·0 cites
- 0365US2018369228A1Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2018·Application pending·0 cites
- 0464US2018250285A1Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2018·Application pending·0 cites
- 0562US2018133209A1Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2017·Application pending·0 cites
- 0662US2017319569A1Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2017·Application pending·0 cites
- 0761US2014088140A1Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2013·Application pending·0 cites
- 0861US2015209346A1Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2013·Application pending·0 cites
- 0957US2014088145A1Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2013·Application pending·0 cites
- 1057US2017354651A1Treatment Of Neurodegenerative Diseases With Combination Of Laquinimod And FingolimodHAYDEN MICHAEL·Filed 2017·Application pending·0 cites
- 1157US2015216850A1Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's diseaseHAYDEN MICHAEL·Filed 2013·Application pending·0 cites
- 1256US2017224674A1Treatment Of Neurodegenerative Diseases With Combination Of Laquinimod And FingolimodHAYDEN MICHAEL·Filed 2017·Application pending·0 cites
- 1354US2011312907A1Polymorphisms predictive of anthracycline- induced cardiotoxicityHAYDEN MICHAEL·Filed 2007·Application pending·0 cites
- 1454US2010062079A1Polymorphisms predictive of platinum-coordinating complex induced ototoxicityHAYDEN MICHAEL·Filed 2007·Application pending·0 cites
- 1552US2016074380A1Treatment Of Neurodegenerative Diseases With Combination Of Laquinimod And FingolimodHAYDEN MICHAEL·Filed 2015·Application pending·0 cites
- 1645US5319906AStage platform assembly and method of making sameHAYDEN MICHAEL·Filed 1992·Granted Jun 14, 1994·16 cites·8 claims
- 1726US2017003277A1Biological characterization of a glatiramer acetate related drug product using mammalian and human cellsHAYDEN MICHAEL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HAYDEN MICHAEL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →